Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
rhus toxicodendron is a homeopathic preparation derived from the poison ivy plant (*Toxicodendron radicans*). In homeopathic medicine, it is one of the most frequently prescribed remedies for musculoskeletal conditions, particularly those involving joint pain, stiffness, and inflammation that improves with continued motion. The preparation is created through a process of serial dilution and succussion; the '30' potency indicates a 10^-60 dilution. It has been evaluated in clinical settings, including a Phase 2 multicenter study sponsored by the Healthcare Homoeo Charitable Society, for its potential safety and efficacy in treating active rheumatoid arthritis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on rhus toxicodendron (Healthcare Homoeo Charitable Society).